These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 20582533)
1. Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. Li Z; Rich JN Curr Top Microbiol Immunol; 2010; 345():21-30. PubMed ID: 20582533 [TBL] [Abstract][Full Text] [Related]
2. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α. Schöning JP; Monteiro M; Gu W Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360 [TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells and hypoxia-inducible factors (Review). Tong WW; Tong GH; Liu Y Int J Oncol; 2018 Aug; 53(2):469-476. PubMed ID: 29845228 [TBL] [Abstract][Full Text] [Related]
4. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Heddleston JM; Li Z; McLendon RE; Hjelmeland AB; Rich JN Cell Cycle; 2009 Oct; 8(20):3274-84. PubMed ID: 19770585 [TBL] [Abstract][Full Text] [Related]
5. Emerging roles of hypoxia-inducible factors and reactive oxygen species in cancer and pluripotent stem cells. Saito S; Lin YC; Tsai MH; Lin CS; Murayama Y; Sato R; Yokoyama KK Kaohsiung J Med Sci; 2015 Jun; 31(6):279-86. PubMed ID: 26043406 [TBL] [Abstract][Full Text] [Related]
6. The hypoxia-inducible factors HIF1α and HIF2α are dispensable for embryonic muscle development but essential for postnatal muscle regeneration. Yang X; Yang S; Wang C; Kuang S J Biol Chem; 2017 Apr; 292(14):5981-5991. PubMed ID: 28232488 [TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer. Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Li Z; Bao S; Wu Q; Wang H; Eyler C; Sathornsumetee S; Shi Q; Cao Y; Lathia J; McLendon RE; Hjelmeland AB; Rich JN Cancer Cell; 2009 Jun; 15(6):501-13. PubMed ID: 19477429 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors. Semenza GL Clin Sci (Lond); 2015 Dec; 129(12):1037-45. PubMed ID: 26405042 [TBL] [Abstract][Full Text] [Related]
10. HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy. Kwak JH; Lee NH; Lee HY; Hong IS; Nam JS Oncotarget; 2016 Jul; 7(28):43518-43533. PubMed ID: 27270657 [TBL] [Abstract][Full Text] [Related]
11. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression. Philip B; Ito K; Moreno-Sánchez R; Ralph SJ Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838 [TBL] [Abstract][Full Text] [Related]
12. Cell metabolism under microenvironmental low oxygen tension levels in stemness, proliferation and pluripotency. De Miguel MP; Alcaina Y; de la Maza DS; Lopez-Iglesias P Curr Mol Med; 2015; 15(4):343-59. PubMed ID: 25941818 [TBL] [Abstract][Full Text] [Related]
13. The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma. Martin SK; Diamond P; Gronthos S; Peet DJ; Zannettino AC Leukemia; 2011 Oct; 25(10):1533-42. PubMed ID: 21637285 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factors, stem cells, and cancer. Keith B; Simon MC Cell; 2007 May; 129(3):465-72. PubMed ID: 17482542 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608 [TBL] [Abstract][Full Text] [Related]
16. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X. Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840 [TBL] [Abstract][Full Text] [Related]
17. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841 [TBL] [Abstract][Full Text] [Related]
18. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Seidel S; Garvalov BK; Wirta V; von Stechow L; Schänzer A; Meletis K; Wolter M; Sommerlad D; Henze AT; Nistér M; Reifenberger G; Lundeberg J; Frisén J; Acker T Brain; 2010 Apr; 133(Pt 4):983-95. PubMed ID: 20375133 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA. Zhang C; Samanta D; Lu H; Bullen JW; Zhang H; Chen I; He X; Semenza GL Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2047-56. PubMed ID: 27001847 [TBL] [Abstract][Full Text] [Related]
20. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Keith B; Johnson RS; Simon MC Nat Rev Cancer; 2011 Dec; 12(1):9-22. PubMed ID: 22169972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]